Fournier Gangreni
Özet
Fournier gangreni, perianal, ürogenital ve perine bölgelerini tutan, hızlı ilerleyen ve yüksek mortalite riskine sahip polimikrobiyal bir nekrotizan fasiit türüdür. Tanısı klinik semptomlara dayanan bu hastalıkta; genital bölgede ödem, ağrı, kötü koku ve nekroz tipik bulgulardır. LRINEC, FGSI ve UFGSI gibi skorlama sistemleri, hastalığın şiddetini ve sağkalım olasılığını öngörmek için yaygın olarak kullanılmaktadır. Tedavinin temel taşı, sağlıklı dokuya ulaşılana dek yapılan acil ve tekrarlayıcı cerrahi debridmandır. Cerrahiye ek olarak, gram-negatif ve MRSA patojenlerini kapsayan geniş spektrumlu ampirik antibiyoterapiye derhal başlanmalıdır. Vakum yardımlı kapama (VAC) ve hiperbarik oksijen tedavisi, yara bakımını kolaylaştıran ve iyileşmeye katkı sağlayan önemli yardımcı yöntemlerdir. Güncel yaklaşım, üroloji, jinekoloji, genel cerrahi, yoğun bakım ve plastik cerrahi uzmanlarını içeren multidisipliner bir takım çalışmasını gerektirir.
Fournier's gangrene is a rapidly progressing polymicrobial necrotizing fasciitis of the perianal, urogenital, and perineal regions with a high risk of mortality. Diagnosed based on clinical symptoms, typical findings include edema, pain, malodor, and necrosis in the genital area. Scoring systems such as LRINEC, FGSI, and UFGSI are widely used to predict the severity of the disease and the probability of survival. The cornerstone of treatment is urgent and repeated surgical debridement until healthy tissue is reached. In addition to surgery, broad-spectrum empirical antibiotic therapy covering gram-negative and MRSA pathogens should be initiated immediately. Vacuum-assisted closure (VAC) and hyperbaric oxygen therapy are important adjunctive methods that facilitate wound care and contribute to healing. Modern management requires a multidisciplinary team approach involving specialists in urology, gynecology, general surgery, intensive care, and plastic surgery.
Referanslar
Boughanmi F, Ennaceur F, Korbi I, et al. Fournier’s gangrene: its management remains a challenge. The Pan African Medical Journal. 2021;38: 1–8. doi:10.11604/PAMJ.2021.38.23.25863
Smith G, Bunker C, Dinneen M. Fournier’s gangrene. British journal of urology. Br J Urol; 1998;81(3): 347–355. doi:10.1046/J.1464-410X.1998.00532.X
JA F. Jean-Alfred Fournier 1832-1914. Gangrène foudroyante de la verge (overwhelming gangrene). Sem Med 1883. Diseases of the colon and rectum. Dis Colon Rectum; 1988;31(12): 984–988. doi:10.1007/BF02554904
Madineh SMA. Avicenna’s Canon of Medicine and modern urology part II: Bladder calculi. Urology Journal. 2009;6(1): 63–68.
Litchfield WR. The bittersweet demise of Herod the Great: http://dx.doi.org/10.1177/014107689809100513. SAGE PublicationsSage UK: London, England; 2017;91(5): 283–284. doi:10.1177/014107689809100513
Short B. Fournier gangrene: an historical reappraisal. Internal Medicine Journal. John Wiley & Sons, Ltd; 2018;48(9): 1157–1160. doi:10.1111/IMJ.14031
Sroczyński M, Sebastian M, Rudnicki J, et al. A Complex Approach to the Treatment of Fournier’s Gangrene Kompleksowe podejście do leczenia zgorzeli Fourniera.
Wróblewska M, Kuzaka B, Borkowski T, Kuzaka P, Kawecki D RP. Fournier’s gangrene--current concepts - PubMed. Pol J Microbiol. 2014;63(3): 267–273. https://pubmed.ncbi.nlm.nih.gov/25546936/
Thwaini A, Khan A, Malik A, et al. Fournier’s gangrene and its emergency management. Postgraduate Medical Journal. BMJ Publishing Group; 2006;82(970): 516. doi:10.1136/PGMJ.2005.042069
Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections. Critical Care Medicine. 2004;32(7): 1535–1541. doi:10.1097/01.CCM.0000129486.35458.7D
Laor E, Palmer LS, Tolia BM, et al. Outcome Prediction in Patients with Fournier’s Gangrene. The Journal of Urology. 1995;154(1): 89–92. doi:10.1016/S0022-5347(01)67236-7
Yilmazlar T, Ozturk E, Ozguc H, et al. Fournier’s gangrene: An analysis of 80 patients and a novel scoring system. Techniques in Coloproctology. Springer; 2010;14(3): 217–223. doi:10.1007/S10151-010-0592-1/TABLES/4
Alzerwi NA, Alshanwani M, Alsultan AS, et al. Perforated appendicitis as a source of Fournier’s gangrene in an immunocompetent male. International Surgery Journal. 2019;6(10): 3813. doi:10.18203/2349-2902.isj20194446
Chawla SN, Gallop C, Mydlo JH. Fournier’s gangrene: an analysis of repeated surgical debridement. European urology. Eur Urol; 2003;43(5): 572–575. doi:10.1016/S0302-2838(03)00102-7
Chen XH, Qin PP, Zhang ZX, et al. A novel surgical debridement technique for the treatment of Fournier’s gangrene. Asian journal of andrology. Asian J Androl; 2021;23(5): 541–542. doi:10.4103/AJA.AJA_6_21
Alyaqout K, AlQinai S, Almazeedi S, et al. Applying augmented reality to treat Fournier’s gangrene in COVID-19 positive patients whilst safeguarding the multi-disciplinary surgical team: A case series. International Journal of Surgery Case Reports. Elsevier; 2021;79: 335. doi:10.1016/J.IJSCR.2021.01.055
Brahmi Y El, Fahssi M El, Elhjouji A, et al. The Role of Colostomy in Management of Fournier’s Gangrene. Journal of Advances in Medicine and Medical Research. Sciencedomain International; 2020;32(23): 120–125. doi:10.9734/JAMMR/2020/V32I2330723
Giné PP, Rodríguez-Hermosa JI, Bassols CC, et al. Role of derivative colostomy in Fournier’s gangrene: Analysis of 46 cases. Surgical Practice. John Wiley & Sons, Ltd; 2017;21(3): 111–115. doi:10.1111/1744-1633.12255
Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World Journal of Emergency Surgery 2018 13:1. BioMed Central; 2018;13(1): 1–24. doi:10.1186/S13017-018-0219-9
Eray IC, Alabaz O, Akcam AT, et al. Comparison of Diverting Colostomy and Bowel Management Catheter Applications in Fournier Gangrene Cases Requiring Fecal Diversion. The Indian Journal of Surgery. Springer; 2015;77(Suppl 2): 438. doi:10.1007/S12262-013-0868-6
Trygonis S, Lazaridis C, Apostolou C, et al. Use of rectal catheter prevents diversion colostomy in a patient with Fournier’s Gangrene. Hellenic Journal of Surgery 2011 83:4. Springer; 2011;83(4): 235–238. doi:10.1007/S13126-011-0035-0
Estrada O, Martinez I, Del Bas M, et al. Rectal diversion without colostomy in Fournier’s gangrene. Techniques in coloproctology. Tech Coloproctol; 2009;13(2): 157–159. doi:10.1007/S10151-009-0474-6
Bjurlin MA, O’Grady T, Kim DY, et al. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier’s gangrene. Urology. Urology; 2013;81(4): 752–759. doi:10.1016/J.UROLOGY.2012.12.041
LinWei-Ting, ChaoChien-Ming, LinHsin-Lan, et al. Emergence of Antibiotic-Resistant Bacteria in Patients with Fournier Gangrene. https://home.liebertpub.com/sur. Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA ; 2015;16(2): 165–168. doi:10.1089/SUR.2013.118
Takano N, Yatabe MS, Yatabe J, et al. Fatal Fournier’s gangrene caused by Clostridium ramosum in a patient with central diabetes insipidus and insulin-dependent diabetes mellitus: a case report. BMC Infectious Diseases. BioMed Central; 2018;18(1). doi:10.1186/S12879-018-3280-9
Kumar, Pushkarna A, Sharma V, et al. Fournier’s gangrene with testicular infarction caused by mucormycosis. Indian Journal of Pathology and Microbiology. Medknow Publications and Media Pvt. Ltd.; 2011;54(4): 847. doi:10.4103/0377-4929.91520
Mallikarjuna MN, Vijayakumar A, Patil VS, et al. Fournier’s Gangrene: Current Practices. ISRN Surgery. Hindawi Limited; 2012;2012: 1–8. doi:10.5402/2012/942437
Oguz A, Gümüş M, Turkoglu A, et al. Fournier’s Gangrene: A Summary of 10 Years of Clinical Experience. International Surgery. International College of Surgeons; 2015;100(5): 934. doi:10.9738/INTSURG-D-15-00036.1
Ozturk E, Ozguc H, Yilmazlar T. The use of vacuum assisted closure therapy in the management of Fournier’s gangrene. American journal of surgery. Am J Surg; 2009;197(5): 660–665. doi:10.1016/J.AMJSURG.2008.04.018
Syllaios A, Davakis S, Karydakis L, et al. Treatment of Fournier’s Gangrene With Vacuum-assisted Closure Therapy as Enhanced Recovery Treatment Modality. In vivo (Athens, Greece). In Vivo; 2020;34(3): 1499–1502. doi:10.21873/INVIVO.11936
Franco-Buenaventura D, García-Perdomo HA. Vacuum-assisted closure device in the postoperative wound care for Fournier’s gangrene: a systematic review. International urology and nephrology. Int Urol Nephrol; 2021;53(4): 641–653. doi:10.1007/S11255-020-02705-6
Gul MO, Sunamak O, Kina U, et al. Fournier’s Gangrene: Our Five-Year Series and the Role of Vacuum-Assisted Closure in the Treatment. Nigerian journal of clinical practice. Niger J Clin Pract; 2021;24(9): 1277–1282. doi:10.4103/NJCP.NJCP_387_20
Grabińska A, Michalczyk L, Banaczyk B, et al. Management protocol for Fournier’s gangrene in sanitary regime caused by SARS-CoV-2 pandemic: A case report. World journal of clinical cases. World J Clin Cases; 2021;9(5): 1215–1220. doi:10.12998/WJCC.V9.I5.1215
Schneidewind L, Anheuser P, Schönburg S, et al. Hyperbaric Oxygenation in the Treatment of Fournier’s Gangrene: A Systematic Review. Urologia internationalis. 2021;105(3–4): 247–256. doi:10.1159/000511615
Jull AB, Cullum N, Dumville JC, et al. Honey as a topical treatment for wounds. The Cochrane database of systematic reviews. Cochrane Database Syst Rev; 2015;2015(3). doi:10.1002/14651858.CD005083.PUB4
Haidari M, Nazer MR, Ahmadinejad M, et al. Honey in the treatment of Fournier’s gangrene as an adjuvant: a cross sectional study. JPMA. The Journal of the Pakistan Medical Association. Pakistan; 2014;64(5): 571–573.
Hejase MJ, Simonin JE, Bihrle R, et al. Genital Fournier’s gangrene: experience with 38 patients. Urology. Urology; 1996;47(5): 734–739. doi:10.1016/S0090-4295(96)80017-3
Al-Meshaan M, Hamid MA, Quider T, et al. Role of Mebo (Moist Exposed Burn Ointment) in the Treatment of Fournier’S Gangrene. Annals of Burns and Fire Disasters. Euro-Mediterranean Council for Burns and Fire Disasters (MBC); 2008;21(1): 20. /pmc/articles/PMC3188123/
Felder JM, Hechenbleikner E, Jordan M, et al. Increasing the options for management of large and complex chronic wounds with a scalable, closed-system dressing for maggot therapy. Journal of burn care & research : official publication of the American Burn Association. J Burn Care Res; 2012;33(3). doi:10.1097/BCR.0B013E318233570D
Fonseca-Muñoz A, Sarmiento-Jiménez HE, Pérez-Pacheco R, et al. Clinical study of Maggot therapy for Fournier’s gangrene. International Wound Journal. Wiley-Blackwell; 2020;17(6): 1642. doi:10.1111/IWJ.13444
